REUTERS: The U.S. Food and Drug Administration on Friday approved Alexion Pharmaceuticals Inc's treatment for a second rare blood disorder, the company said.
The treatment, Ultomiris, has already been approved in the United States, Japan and the European Union to treat adults with blood disorder called paroxysmal nocturnal hemoglobinuria.Friday's approval allows its use in treating atypical hemolytic uremic syndrome , a condition that causes abnormal blood clots to form in small blood vessels in the kidneys, which could result in kidney failure.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:
Health Health Latest News, Health Health Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
More than half of Wisconsin vaping samples tested by FDA contain marijuana ingredientVaping product samples from Wisconsin linked to a rash of serious lung injuries tested by U.S. health regulators showed that more than half ...
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »
Johnson & Johnson to recall some baby powder as FDA finds traces of asbestosJohnson & Johnson said on Friday it is recalling around 33,000 bottles of baby powder in the United States after U.S. health regulators found ...
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »
J&J recalls 33,000 bottles of baby powder as FDA finds asbestos in sampleJohnson & Johnson said on Friday it is recalling around 33,000 bottles of baby powder in the United States after U.S. health regulators found ...
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »
More than half of Wisconsin vaping samples tested by FDA contain marijuana ingredientVaping product samples from Wisconsin linked to a rash of serious lung injuries tested by U.S. health regulators showed that more than half ...
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »